Milnacipran Hydrochloride and Oxycodone and naloxone
Determining the interaction of Milnacipran Hydrochloride and Oxycodone and naloxone and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:The following interaction applies only if you are using naloxone in an injectable formulation: naloxone can reverse the effects of oxyCODONE. If you are a physically dependent patient you may experience withdrawal symptoms. This can cause nausea, vomiting, diarrhea, aches, fever, runny nose, sneezing, nervousness, irritability, shivering, and abdominal cramps. Talk to your doctor if you have any questions or concerns. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: This warning does not apply to the naloxone component in non-injectable formulations of naloxone-containing combination medicines. Naloxone injection is an antagonist that will reverse the actions of opiates. This reversal can occur when the opiate drug is being used clinically and when it is being abused. Physically dependent patients may experience withdrawal symptoms. Abrupt postoperative opioid reversal has resulted in hypotension, ventricular tachycardia and fibrillation, pulmonary edema, cardiac arrest, encephalopathy, and death.
MANAGEMENT: Patients receiving naloxone injection should be monitored for changes in vital signs, nausea, vomiting, diarrhea, aches, fever, runny nose, sneezing, nervousness, irritability, shivering, abdominal cramps.
- Cerner Multum, Inc. "Australian Product Information." O 0
- Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Narcan (naloxone)." DuPont Pharmaceuticals, Wilmington, DE.
Generic Name: milnacipran
Brand name: Savella, Savella Titration Pack
Synonyms: Milnacipran
Generic Name: naloxone / oxycodone
Brand name: Targiniq ER
Synonyms: Oxycodone and naloxone (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Milnacipran Hydrochloride-Oxycodone and naltrexone
- Milnacipran Hydrochloride-Oxycodone Capsules
- Milnacipran Hydrochloride-Oxycodone Capsules and Tablets
- Milnacipran Hydrochloride-Oxycodone Concentrate
- Milnacipran Hydrochloride-Oxycodone ER
- Milnacipran Hydrochloride-Oxycodone Extended-Release Capsules
- Oxycodone and naloxone-Milrinone
- Oxycodone and naloxone-Milrinone Dextrose
- Oxycodone and naloxone-Milrinone Injection
- Oxycodone and naloxone-Milrinone Lactate
- Oxycodone and naloxone-Milrinone Lactate in Dextrose Injection
- Oxycodone and naloxone-Miltefosine